<DOC>
	<DOC>NCT02917512</DOC>
	<brief_summary>A multicenter, Placebo controlled, RestasisÂ® referenced, Randomized, Double blind, Phase II Study to Evaluate the Efficacy and Safety of HU00701/HU007 Eye Drops in Adult Patients with Dry Eye Syndrome</brief_summary>
	<brief_title>Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>age over 19 Corneal staining score(Oxford grading) &gt; 2 or Schirmer test &lt; 10mm/5min (If Schirmer test = 0mm/5min, Nasal stimulation schirmer test &gt; 3mm/5min) Volunteer who went through menopause more than 1 years ago before screening or has surgical menopause Volunteer who has negative result of pregnancy test or use effective contraception Current or recent patients used dry eye syndrome medications (topical or systemic) that may affect the status The patients with systemic or ocular disorders affected the test result Being treated with systemic steroid Wearing contact lenses within 3 days of screening visit Pregnancy or Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>